SCHEMBL4631325

SCHEMBL4631325

CCOC(=O)c1ccc(NC(C)=O)cc1-c1c2ccc(=O)cc-2oc2cc(OCC(=O)OC(C)(C)C)ccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.41
ALDH1A1 P00352 7/20 0.40
HPGD P15428 7/20 0.40
MAPT P10636 4/20 0.40
HSD17B10 Q99714 3/20 0.40
GLA P06280 2/20 0.40
GAA P10253 2/20 0.40
MAPK1 P28482 2/20 0.40
TP53 P04637 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
LMNA P02545 2/20 0.39
CA12 O43570 5/20 0.39
CA1 P00915 5/20 0.39
CA2 P00918 5/20 0.39
CA9 Q16790 4/20 0.39
DNASE1L3 Q13609 1/20 0.38
PRMT1 Q99873 1/20 0.38
MAOB P27338 1/20 0.37
CA4 P22748 1/20 0.37
CA5A P35218 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4630010 0.95 CA9 (0.42) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL4631742 0.90 MAPT (0.42) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL4630648 0.90 CA1 (0.42) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL4630565 0.88 USP2 (0.47) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL4630755 0.85 MAPT (0.42) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL4630894 0.84 USP2 (0.50) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL4630027 0.84 CA9 (0.46) KDM4EALDH1A1HPGDMAPTGLA
SCHEMBL4937655 0.82 ALDH1A1 (0.37) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL14008335 0.79 KDM4E (0.51) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL4630833 0.78 ALDH1A1 (0.38) KDM4EALDH1A1HPGDMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275215-A1 Fluorescein-Based Compounds And Their Use For Peptide Synthesis COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-11-06 US disclosed
EP-1749870-B1 Fluorescein-based compounds and their use for peptide synthesis COMMISSARIAT ENERGIE ATOMIQUE (FR) 2008-05-14 EP disclosed
EP-1749870-A1 Fluorescein-based compounds and their use for peptide synthesis COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2007-02-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275215-A1 Fluorescein-Based Compounds And Their Use For Peptide Synthesis DNPEP, ANPEP, PEPD KDM4E 4808/4885ALDH1A1 3716/4885HPGD 2522/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.